| dc.creator | Pavlakou P., Liakopoulos V., Eleftheriadis T., Mitsis M., Dounousi E. | en |
| dc.date.accessioned | 2023-01-31T09:46:29Z | |
| dc.date.available | 2023-01-31T09:46:29Z | |
| dc.date.issued | 2017 | |
| dc.identifier | 10.1155/2017/6193694 | |
| dc.identifier.issn | 19420900 | |
| dc.identifier.uri | http://hdl.handle.net/11615/77994 | |
| dc.description.abstract | Acute kidney injury (AKI) is a multifactorial entity that occurs in a variety of clinical settings. Although AKI is not a usual reason for intensive care unit (ICU) admission, it often complicates critically ill patients' clinical course requiring renal replacement therapy progressing sometimes to end-stage renal disease and increasing mortality. The causes of AKI in the group of ICU patients are further complicated from damaged metabolic state, systemic inflammation, sepsis, and hemodynamic dysregulations, leading to an imbalance that generates oxidative stress response. Abundant experimental and to a less extent clinical data support the important role of oxidative stress-related mechanisms in the injury phase of AKI. The purpose of this article is to present the main pathophysiologic mechanisms of AKI in ICU patients focusing on the different aspects of oxidative stress generation, the available evidence of interventional measures for AKI prevention, biomarkers used in a clinical setting, and future perspectives in oxidative stress regulation. © 2017 Paraskevi Pavlakou et al. | en |
| dc.language.iso | en | en |
| dc.source | Oxidative Medicine and Cellular Longevity | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031907884&doi=10.1155%2f2017%2f6193694&partnerID=40&md5=1f502ae1256d05580f921e205eea11c4 | |
| dc.subject | Biomarkers | en |
| dc.subject | Disease control | en |
| dc.subject | Diseases | en |
| dc.subject | Oxidative stress | en |
| dc.subject | Patient treatment | en |
| dc.subject | Clinical settings | en |
| dc.subject | Critically-ill patients | en |
| dc.subject | End stage renal disease | en |
| dc.subject | Future perspectives | en |
| dc.subject | Oxidative stress response | en |
| dc.subject | Renal replacement therapies | en |
| dc.subject | Stress generation | en |
| dc.subject | Systemic inflammation | en |
| dc.subject | Intensive care units | en |
| dc.subject | biological marker | en |
| dc.subject | nitric oxide | en |
| dc.subject | reactive oxygen metabolite | en |
| dc.subject | toll like receptor | en |
| dc.subject | biological marker | en |
| dc.subject | acute kidney failure | en |
| dc.subject | aerobic metabolism | en |
| dc.subject | antioxidant activity | en |
| dc.subject | autophagy | en |
| dc.subject | cell cycle arrest | en |
| dc.subject | cell damage | en |
| dc.subject | critical illness | en |
| dc.subject | critically ill patient | en |
| dc.subject | disease course | en |
| dc.subject | end stage renal disease | en |
| dc.subject | homeostasis | en |
| dc.subject | hospital admission | en |
| dc.subject | human | en |
| dc.subject | intensive care unit | en |
| dc.subject | oxidative stress | en |
| dc.subject | renal replacement therapy | en |
| dc.subject | Review | en |
| dc.subject | acute kidney failure | en |
| dc.subject | chemistry | en |
| dc.subject | female | en |
| dc.subject | genetics | en |
| dc.subject | male | en |
| dc.subject | oxidative stress | en |
| dc.subject | pathology | en |
| dc.subject | Diseases | en |
| dc.subject | Pathology | en |
| dc.subject | Physiology | en |
| dc.subject | Acute Kidney Injury | en |
| dc.subject | Biomarkers | en |
| dc.subject | Critical Illness | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Oxidative Stress | en |
| dc.subject | Hindawi Limited | en |
| dc.title | Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms - Biomarkers - Interventions, and Future Perspectives | en |
| dc.type | other | en |